stars 1 stars 2 stars 3

Innogenix is an emerging pharmaceutical company based on Long Island, focused on the development, manufacturing, and commercialization of niche, specialty, and hard-to-manufacture generic drugs. We are committed to delivering high-quality, affordable medicines by building a diversified portfolio of complex generics and specialty products. Our robust pipeline includes ANDAs, 505(b)(2) applications, and Paragraph IV filings, positioning us to meet critical therapeutic needs across the U.S. healthcare system. At Innogenix, our mission is to provide physicians and patients with reliable access to essential medicines while maintaining the highest standards of quality, safety, and compliance.

Innogenix Inc. Questions

The Innogenix Inc. annual revenue was $4 million in 2026.

Sita Nuti is the Director of Regulatory Affairs of Innogenix Inc..

11 people are employed at Innogenix Inc..

Innogenix Inc. is based in Amityville, New York.

The NAICS codes for Innogenix Inc. are [32541, 3254, 325, 32].

The SIC codes for Innogenix Inc. are [28, 283].

Top Innogenix Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users